Max Récasens

Anxiolytic properties of green tea polyphenol (-)-epigallocatechin gallate (EGCG).

Naturally occurring polyphenols are potent antioxidants. Some of these compounds are also ligands for the GABA(A) receptor benzodiazepine site. This feature endows them with sedative properties. Here, the anxiolytic activity of the green tea polyphenol (-)-epigallocatechin gallate (EGCG) was investigated after acute administration in mice, using behavioral tests (elevated plus-maze and passive avoidance tests) and by electrophysiology on cultured hippocampal neurons. Patch-clamp experiments revealed that EGCG (1-10 muM) had no effect on GABA currents. However, EGCG reversed GABA(A) receptor negative modulator methyl beta-carboline-3-carboxylate (beta-CCM) inhibition on GABA currents in a concentration dependent manner. This was also observed at the level of synaptic GABA(A) receptors by recording spontaneous inhibitory synaptic transmission. In addition, EGCG consistently inhibited spontaneous excitatory synaptic transmission. Behavioral tests indicated that EGCG exerted both anxiolytic and amnesic effects just like the benzodiazepine drug, chlordiazepoxide. Indeed, EGCG in a dose-dependent manner both increased the time spent in open arms of the plus-maze and decreased the step-down latency in the passive avoidance test. GABA(A) negative modulator beta-CCM antagonized EGCG-induced amnesia. Finally, state-dependent learning was observable after chlordiazepoxide and EGCG administration using a modified passive avoidance procedure. Optimal retention was observed only when animals were trained and tested in the same state (veh-veh or drug-drug) and significant retrieval alteration was observed in different states (veh-drug or drug-veh). Moreover, EGCG and chlordiazepoxide fully generalized in substitution studies, indicating that they induced indistinguishable chemical states for the brain. Therefore, our data support that EGCG can induce anxiolytic activity which could result from an interaction with GABA(A) receptors.

Sex differences in learning deficits induced by prenatal stress in juvenile rats

Stress during pregnancy results in neurochemical and behavioral alterations observed throughout adulthood and aging. We here examined the impact of prenatal stress (PS) on cognitive functions in juvenile-4-week-old-rats, focusing on putative sex differences. Dams received an unpredictable 90-min duration contention stress between gestational day E17 and E20. Locomotion and learning ability were examined in offsprings between day P24 and P29 using actimetry, spontaneous alternation in the Y-maze, delayed alternation in the T-maze, and passive avoidance. Both male and female PS rats showed increased activity. In the Y-maze, diminished spontaneous alternation (males: -20%; females: -29%) were seen for PS rats compared to non-PS rats. The number of arm entries was unchanged among groups. In the T-maze, PS rats failed to perform delayed alternation, as shown by equal time spent and number of entries in both the novel and previously explored arms. In the passive avoidance test, PS resulted in significant impairments for female offspring only of both step-through latency and percentage of animals to criterion. PS thus induced severe learning impairments affecting both short-term and long-term memories that could be observed early in lifetime, in 4-week-old, juvenile rats. In addition, marked sex differences were evidenced, particularly in the passive avoidance response that may reflect differential developmental neuroadaptations in precise brain structures.

Glutamate Neurotoxicity in the Cochlea: A Possible Consequence of Ischaemic or Anoxic Conditions Occurring in Ageing

Glutamate is considered to be one of the most common neurotransmitters in the fast excitatory synapses in the central nervous system. On the other hand, its excitotoxic properties are increasingly cited to explain some of the brain damage linked with hypoxia and ischaemia: i.e., those that occur frequently in ageing. An excess release of glutamate could, either directly or indirectly, activate receptors on the postsynaptic neuron, causing ion influxes accompanied by a massive entry of water, which would lead to an acute swelling of dendrites. In addition, calcium influx deregulates calcium homeostasis, which could lead to cell death. In the cochlea, glutamate is now considered to be one of the best candidates to mediate neurotransmission between inner hair cells (IHCs) and the auditory nerve dendrites. Among the variety of anatomical and physiological findings supporting the glutamate hypothesis, is the striking similarity of acute damage in the organ of Corti caused by exposure to a glutamate analogue (kainic acid), or by hypoxia, or even by an intense loud noise. In all cases an immediate swelling is observed, specifically affecting the radial afferents below the IHCs. The best explanation for this swelling is related to glutamate (or glutamate analogue) excitotoxicity. Thus, some of the cochlear damage that occur with ageing, especially the loss of the radial afferent fibres and type I ganglion cells, might well be attributed to glutamate excitotoxicity linked to vascular atrophy. The present paper discusses this hypothesis.

Transient expression of the glial glutamate transporters GLAST and GLT in hippocampal neurons in primary culture.

The extracellular glutamate concentration is kept low by glutamate transporters in the plasma membranes. Here we have studied the expression of the glutamate transporters GLAST, GLT and EAAC during the in vitro development of embryonic hippocampal neurons grown in a defined (serum free) medium. Immunochemistry studies showed that both the GLAST and GLT proteins are expressed in a subpopulation of neurons at the early, but not at the later stages of the cultures. Glial cells expressing the GLAST and GLT proteins were found at all stages. EAAC was only detected in neurons. This is one of the first evidence of a neuronal ability to express GLAST. J. Neurosci. Res. 59:587–593, 2000

Attenuation by a sigma1 (σ1) receptor agonist of the learning and memory deficits induced by a prenatal restraint stress in juvenile rats

Stress during pregnancy results in complex neurochemical and behavioral alterations throughout the offspring lifetime. We here examined the impact of prenatal stress (PS) on memory functions in male and female offspring and report the efficacy of a selective sigma1 (σ1) receptor agonist, igmesine, in alleviating the observed deficits. Dams received an unpredictable 90‐min duration restraint stress from gestational day E17 to E20. Learning was examined in offspring between day P24 and P36 using spontaneous alternation in the Y‐maze, delayed alternation in the T‐maze, water‐maze learning and passive avoidance. Both male and female PS rats showed impairments of spontaneous and delayed alternation performances. Acquisition of a fixed platform position in the water‐maze was unchanged in PS rats, but the probe test revealed a diminution of time spent in the training quadrant. Acquisition of a daily changing platform position demonstrated impaired working memory for male and female PS rats. Finally, passive avoidance deficits were observed. Pretreatment with the selective σ1 agonist igmesine (1–10 mg kg−1 i.p.) reversed the PS‐induced learning deficits in offspring rats for each test. The σ1 antagonist BD1063 failed to affect performances alone but blocked the igmesine effect, confirming the involvement of the σ1 receptor. PS thus induces delayed memory deficits, affecting spatial and nonspatial, short‐ and long‐term memories in juvenile male and female offspring rats. Activation of the σ1 neuromodulatory receptor allows a significant recovery of the memory functions in PS rats.

Carbachol-induced inositol phosphate formation during rat cochlea development

The age related-intensity developmental pattern of the phosphoinositide breakdown, which leads to the formation of intracellular second messengers, was investigated in rat cochleas by measuring the accumulation of inositol phosphates induced by carbachol in the presence of LiCl. The accumulation of the phosphoinositide metabolites elicited by this muscarinic agonist is very low at post-natal day 1 and particularly large during the period between post-natal days 8 and 14 with a peak around day 12. In the 25-day-old rat cochlea, carbachol induced a 2-fold increase in inositol phosphates (IPs) accumulation, with respect to the basal control level. The apparent affinities of the carbachol-induced IPs responses are 49.6, 31.6 and 36.7 microM in cochleas of 12-, 16- and 25-day-old rats, respectively, thus suggesting that the specific developmental changes are rather due to a modification in the number of muscarinic cholinergic receptors than to alterations of the apparent affinity of carbachol for its receptors. This developmental pattern of carbachol-elicited IPs accumulation reveals a striking time coincidence with both the efferent synaptogenesis at the outer hair cells (OHCs) level and the period of increased sensitivity of OHCs to aminoglycoside toxicity. Phosphoinositide breakdown may, consequently, play a role in the maturation of OHCs and their efferent supply. In addition, the remaining IPs response measured at 25 post-natal days indicates that muscarinic agonist-mediated IPs metabolism also occurs in mature cochlea, and might be involved in the regulation of OHCs motility.

Potentiation of glutamatergic agonist-induced inositol phosphate formation by basic fibroblast growth factor is related to developmental features in hippocampal cultures: neuronal survival and glial cell proliferation.

We investigated the modulation by growth factors of phospholipase C (PLC)‐linked glutamate receptors during in vitro development of hippocampal cultures. In defined medium, glial cells represent between 3 and 14% of total cell number. When we added basic fibroblast growth factor (bFGF) 2 h after plating, we found: (i) a neuroprotection from naturally occurring death for up to 5 days; (ii) a proliferation of glial cells from day 3; and (iii) a potentiation of quisqualate (QA)‐induced inositol phosphate (IP) formation from 1 to 10 days in vitro (DIV) and 1s,3r‐amino‐cyclopentane‐1,3‐dicarboxylate (ACPD) response from 3 to 10 DIV. The antimitotic cytosine‐β,d‐arabinofuranoside (AraC) blocked glial cell proliferation induced by bFGF, but not neuroprotection. Under these conditions, the early potentiation of the QA response (1–3 DIV) was not changed, while the ACPD and late QA response potentiations were prevented (5–10 DIV). Epidermal growth factor was not neuroprotective but it induced both glial cell proliferation and late QA or ACPD potentiation. Surprisingly, the early bFGF‐potentiated QA‐induced IP response was blocked by 6,7‐dinitro‐quinoxaline‐2,3‐dione (DNQX), suggesting the participation of ionotropic (rs)‐α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionate (AMPA)/kainate (KA) receptors. The delayed bFGF‐potentiated ACPD‐induced IP response is inhibited by (s)‐α‐methyl‐4‐carboxyphenylglycine (MCPG), indicating possible activation of glial metabotropic receptors. These results suggest that, in hippocampal cultures, bFGF modulates AMPA and metabotropic glutamate receptors linked to the IP cascade, possibly in relation to the regulation of neuronal survival and glial cell proliferation, respectively.

Transient increase in the high affinity [3H]-l-glutamate uptake activity during in vitro development of hippocampal neurons in culture

The glial GLAST and GLT-1 glutamate transporters are transiently expressed in hippocampal neurons as shown by immunocytochemistry (Plachez et al., 2000. J. Neurosci. Res., 59, 587-593). In order to test if this transient expression is associated to a transient glutamate uptake activity, [3H]-glutamate uptake was studied during the in vitro development of embryonic hippocampal neurons cultured in a defined (serum free) medium. In these cultures, the ratio of the number of glial cells to the number of neurons increased from 1.7 to 11.3% during the first 10 days of culture, while 77% of the neurons died. The number of neurons then remains stable up to 23 days of culture. The initial glutamate uptake velocity at 20 and 200 microM [3H]-glutamate usually increased about five times between 1 and 10 days in vitro (DIV). Interestingly, at 2 microM [3H]-glutamate, the uptake initial velocity showed a biphasic pattern, with a transient peak between 1 and 6 DIV, the maximum being reached at 2 DIV and a delayed regular increase from 8 to 23 DIV. The concentration-dependent curves were best fitted with two saturable sites high and low affinities, at both 2 and 10 DIV. To pharmacologically characterize the transient increased glutamate uptake activity, four uptake inhibitors, L-threo-3-hydroxy-aspartic acid (THA), L-trans-pyrrolidine-2,4-dicarboxylic acid (L-trans-2,4-PDC), dihydrokainate (DHK), and DL-threo-beta-benzyloxyaspartate (TBOA) were tested. THA, L-trans-2,4-PDC and DL-TBOA inhibited glutamate uptake both at 2 and 10 DIV, while the GLT-1 selective uptake inhibitor DHK neither strongly affected the uptake at 2, nor at 10 DIV. These data indicated that, besides the regular increase in the glial-dependent glutamate uptake activity, a transient high-affinity, DHK insensitive, glutamate transport activity in hippocampal neurons in culture is present. This latter activity could potentially be related to the transient expression of the glial GLAST transporter in neurons.

Excitatory Amino Acid Receptors and Phosphoinositide Breakdown: Facts and Perspectives

Although phosphoinositides were isolated from brain membranes by Folch in 1949, stimulated phosphoinositide metabolism by neuroactive substances was discovered in 1953 by Hokin and Hokin, who showed that the incorporation of 32P into phospholipids of the pancreas was augmented by acetylcholine. In 1961, Dittmer and Dawson (Dawson and Dittmer, 1961; Dittmer and Dawson, 1961) identified these polyphosphoinositides as phosphatidylinositol-4-phosphate (PIP) and phosphatidylinositol-4,5-bisphosphate (PIP2). However, the notion that phosphoinositide metabolism is associated with receptor function was only proposed in 1969 by Durell and co-workers, while a few years later (1975) Michell assumed a close relation between phosphoinositide metabolism and intracellular calcium. Finally, the missing link (inositol trisphosphate) between membrane receptor-coupled phosphoinositide metabolism and the changes in intracellular calcium originating from internal stores was discovered by Berridge and Irvine in 1984.

Astrocytes repress the neuronal expression of GLAST and GLT glutamate transporters in cultured hippocampal neurons from embryonic rats.

Glutamate extracellular levels are regulated by specific transporters. Five subtypes have been identified. The two major ones, GLAST and GLT (glutamate transporters 1 and 2, respectively), are localized in astroglia in normal mature brain. However, in neuron-enriched hippocampal cultures, these proteins are expressed in neurons during the early in vitro development (Plachez et al., 2000). Here, we show that, in these cultures, GLAST and GLT neuronal expression is transient and no longer observed after 7 days in vitro, a stage at which the few astrocytes present in the culture are maturing. Moreover, we demonstrate that these few astrocytes are responsible for the repression of this neuronal expression. Indeed, addition of conditioned medium prepared from primary cultures of hippocampal astrocytes, to cultured hippocampal neurons, rapidly leads to the suppression of neuronal GLAST expression, without affecting neuronal GLT expression. However, when neurons are seeded and co-cultured on a layer of hippocampal astrocytes, they do not develop any immunoreactivity towards GLAST or GLT antibodies. Altogether, these results indicate that glia modulate the expression of GLAST and GLT glutamate transporters in neurons, via at least two distinct mechanisms. Neuronal GLAST expression is likely repressed via the release or the uptake of soluble factors by glia. The repression of neuronal GLT expression probably results from glia-neuron interactions. This further reinforces the fundamental role of direct or indirect neuron-glia interactions in the development of the central nervous system.